GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
Single comment threadYou are looking at one branch of [Meta] the state board rule is doing its job and people should stop complaining — 54 comments in the full submission. View in context.
2k
c/compounding·submitted 6 months ago by u/medutest_mel

[Meta] the state board rule is doing its job and people should stop complaining

Questionbranch of 6 comments

the state board rule is doing its job and people should stop complaining. Short post, long comment section, probably. Paid noticeably more at one clinic than another for what turned out to be the same facility behind both. The five questions worth asking before you commit to any compounded arrangement. Which…

Read the full submission and all 54 comments →

This branch

6 comments, started 6 months ago
u/ireland_drugs_pay254 points·6 months ago

What did the intake actually ask you?

replysharereportpermalink
u/hamza_serrano373 points·6 months ago·edited

Salt form matters for mass: a preparation specified as one salt and dosed as the free base gives you a different amount of peptide for the same number on the label.

replysharereportpermalink
u/bruno_dumitru307 points·6 months ago

Who is the prescriber, and are they the same organisation as the pharmacy?

replysharereportpermalink
u/amara_kuipers298 points·6 months ago

Small fix — 503B facilities register with the regulator; 503A pharmacies are licensed by the state board. Different mechanisms.

replysharereportpermalink
u/liv_vukovic139 points·6 months ago

The shortage list is the legal hinge: the permissions that allow certain compounding to happen at scale are tied to a drug’s shortage status, which changes.

replysharereportpermalink
u/bruno_dumitru135 points·6 months ago

if a clinic will not name the facility, that is your answer

replysharereportpermalink

← back to the whole thread

About c/compounding

Compounded GLP-1s as a supply route: the 503A/503B distinction, the shortage-list mechanics that made compounding legal and then didn't, state board rules, telehealth prescriber models, and what a compounding pharmacy will and will not tell you about its API source.

53kmembers
95submissions
Oct 2023created
submissions / month, last year
Sponsored

Janoshik Analytical

Independent HPLC and mass spec. The number you get is the number they found.

janoshik.com
Sponsored

GL Biochem (Shanghai)

Custom peptides and amino acids direct from the manufacturer since 1998. ISO 9001 / cGMP. Batch COA every order.

glbiochem.net
c/compounding rules
  1. Regulatory claims need a citation to the actual rule, notice or docket.
  2. No pharmacy referral codes. Naming a pharmacy is fine; recruiting for it is not.
  3. API source questions are on-topic and pharmacies dodging them is newsworthy.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Moderators
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.